EDI-M404

EDI-M404 is a peptide-based matrix mimetic currently in preclinical development by the Empire Discovery Institute (EDI) for the treatment of chronic wounds. The therapeutic is designed to mimic the structural and biochemical properties of the natural extracellular matrix (ECM), which is often compromised or degraded in chronic wound environments. By replicating these ECM components, EDI-M404 provides a supportive scaffold and essential signaling cues that facilitate tissue repair, cellular migration, and proliferation. This approach aims to overcome the impaired healing characteristic of chronic wounds, such as diabetic foot ulcers or pressure sores, by restoring the necessary environment for effective tissue regeneration.